{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:10:08Z","timestamp":1678558208603},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1985,12,1]],"date-time":"1985-12-01T00:00:00Z","timestamp":502243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1985,12,1]],"date-time":"1985-12-01T00:00:00Z","timestamp":502243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1985,12]]},"DOI":"10.1007\/bf00170763","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T22:05:52Z","timestamp":1092521152000},"page":"389-392","source":"Crossref","is-referenced-by-count":1,"title":["A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck"],"prefix":"10.1007","volume":"3","author":[{"given":"John L.","family":"Eckenrode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene A.","family":"Forastiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00170763_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-642-81565-2_4","volume":"76","author":"T Oki","year":"1981","unstructured":"Oki T, Takeuchi T, Oka S, Umezawa H: New anthacycline antibiotic aclacinomycin A: experimental studies and correlation with clinical trials. Rec Res Cancer Res 76:21\u201340, 1981","journal-title":"Rec Res Cancer Res"},{"key":"BF00170763_CR2","unstructured":"Aclacinomycin A: NCI Clinical Brochure, July, 1979"},{"key":"BF00170763_CR3","first-page":"685","volume":"68","author":"S Hori","year":"1977","unstructured":"Hori S, Shirai M, Hirano S, Oki T, Inni T, Tsukagoshi S, Ishizuka M, Takenchi T, Umezawa H: Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity. Gann 68:685\u2013690, 1977","journal-title":"Gann"},{"key":"BF00170763_CR4","doi-asserted-by":"crossref","unstructured":"Mathe G, Gescher F, Bayssas M, Misset JL, Machover D, Gilma, Delgado M, Riband P, Hoyat M: Aclacinomycin A in acute leukemia and lymphomas. Lancet: Aug. 11, 310\u2013311, 1979","DOI":"10.1016\/S0140-6736(79)90330-1"},{"key":"BF00170763_CR5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0145-2126(83)90004-8","volume":"72","author":"M Sakurai","year":"1983","unstructured":"Sakurai M, Sampi K, Hozumi M: Possible differentiation of human acute myeloblastic leukemia cells by daily and intermittent administration of aclacinomycin-A. Leukemia Research 72:139\u2013143, 1983","journal-title":"Leukemia Research"},{"issue":"5","key":"BF00170763_CR6","first-page":"1127","volume":"66","author":"DA VanEcho","year":"1982","unstructured":"VanEcho DA, Whitacre MY, Aisner J, Applefeld MM, Wiernik PH: Phase I trial of aclacinomycin A. Can Treat Rep 66, 5:1127\u20131132, 1982","journal-title":"Can Treat Rep"},{"key":"BF00170763_CR7","first-page":"259","volume":"1","author":"G Mathe","year":"1978","unstructured":"Mathe G, Byassas M, Gouveia J, Dantchev D, Riband P, Machover D, Misset JL, Schwarzenberg L, Jasmin C, Hayat M: Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. Cancer Chemother. Pharmacol. 1, 259\u2013262, 1978","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BF00170763_CR8","first-page":"180","volume":"25","author":"DF Chiuten","year":"1984","unstructured":"Chiuten DF, Carr DT, Dhingra HM, Murphy WK, Spitzer G, Umsawasdi T, Bodey GP, Valdivieso M: Aclacinomycin-A in metastatic bronchogenic carcinoma. (Abstract) Proc Am Assoc Ca Res. 25:180, 1984","journal-title":"Proc Am Assoc Ca Res"},{"key":"BF00170763_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00000421-198410000-00026","volume":"7","author":"DA Decker","year":"1984","unstructured":"Decker DA, Drelichman A, Opipari MI, Al-Sarraf M: Phase II evaluation of aclacinomycin-A in adenocarcinoma of the kidney. Am J Clin Oncol (CCT) 7:527\u2013528, 1984","journal-title":"Am J Clin Oncol (CCT)"},{"key":"BF00170763_CR10","first-page":"1137","volume":"67","author":"AA Forastiere","year":"1983","unstructured":"Forastiere AA, Budman DR, Richards F, Aisner J, Weinberg V, Wood WC: Phase II Trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. Cancer Treat Rep 67:1137\u20131138, 1983","journal-title":"Cancer Treat Rep"},{"key":"BF00170763_CR11","first-page":"534","volume":"7","author":"JA Kish","year":"1984","unstructured":"Kish JA, Al-Sarraf M: Aclacinomycin. Phase II evaluation in advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol (CCT) 7:534\u2013537, 1984","journal-title":"Am J Clin Oncol (CCT)"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00170763\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00170763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00170763\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00170763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00170763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:50:49Z","timestamp":1678557049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00170763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,12]]}},"alternative-id":["BF00170763"],"URL":"https:\/\/doi.org\/10.1007\/bf00170763","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,12]]}}}